Primary Angioplasty for the Treatment of Acute ST Elevated Myocardial Infarction: Single Centre Experience

K N Khan1, M H Khan, R Rahman

  • 1Dr Kaisar Nasrullah Khan, Department of Cardiology, United Hospital Limited (UHL), Gulshan, Dhaka, Banglaldesh.

Insights

Primary angioplasty is a safe and effective reperfusion strategy for acute myocardial infarction, achieving high success rates. This study demonstrates its feasibility and positive outcomes in a local hospital setting.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Myocardial Infarction Management

Background:

  • Primary angioplasty is the recommended reperfusion strategy for acute myocardial infarction (AMI) globally.
  • It offers superior reperfusion rates (over 90%) compared to thrombolytics (60-70%).

Purpose of the Study:

  • To evaluate the feasibility, safety, and outcomes of primary angioplasty in patients with AMI at United Hospital.
  • To assess the procedural success and complication rates of primary angioplasty in a specific healthcare setting.

Main Methods:

  • Retrospective observational study of 114 consecutive AMI patients treated with primary angioplasty between March 2007 and January 2011.
  • Exclusion criteria included presentation beyond 12 hours, cardiogenic shock, or pre-procedure intubation.
  • Data collected on patient demographics, risk factors, involved coronary arteries, door-to-balloon times, stent usage, adjunctive medications, complications, and survival rates.

Main Results:

  • The study included 114 patients, predominantly male (89%), with a mean age range of 30-90 years.
  • Common comorbidities included hypertension (58.4%), diabetes (41.5%), and dyslipidemia (43.5%).
  • The Left Anterior Descending (LAD) artery was most frequently involved (57%). Door-to-balloon times ranged from 23 to 184 minutes. Overall survival was high at 97.9%, with reported complications including arrhythmias (24%), hypotension (18%), and no-flow/slow-flow phenomenon (45%).

Conclusions:

  • Primary angioplasty is a feasible and safe reperfusion method for acute myocardial infarction in the studied center.
  • The procedure demonstrated high survival rates, supporting its implementation in similar healthcare settings.
  • Initial experiences suggest confidence in performing primary angioplasty for eligible patients, contributing to improved AMI management.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
347
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
366